E-LIB Suche - Ergebnisse für: Cervi, Paul

1

Hodgkin's Lymphoma- a Review: Future Directions in the Era ..:

Islam, Amin ; Rahman, Md. Mahabubur ; Cervi, Paul.
Haematology Journal of Bangladesh. 3 (2020) 2 - p. 50-59 , 2020

Link: https://doi.org/10.37545..

2

CLL with intra-cytoplasmic lymphocytic inclusion bodies:

Badat, Mohsin ; Oyesanya, Funmi ; Cervi, Paul
International Journal of Hematology. 104 (2016) 4 - p. 411-412 , 2016

Link: https://doi.org/10.1007/..

3

A clinician's guide to biosimilars in oncology:

Rugo, Hope S. ; Linton, Kim M. ; Cervi, Paul..
Cancer Treatment Reviews. 46 (2016) - p. 73-79 , 2016

Link: https://doi.org/10.1016/..

4

Something fishy in the immunocompromised:

Sillito, Francesca ; Cervi, Paul ; Skibinska, Malgorzata
British Journal of Haematology. 153 (2011) 2 - p. 148-148 , 2011

Link: https://doi.org/10.1111/..

5

Thalidomide and bowel perforation: four cases in one hospit..:

McClay, Helen ; Cervi, Paul
British Journal of Haematology. 140 (2007) 3 - p. 360-361 , 2007

Link: https://doi.org/10.1111/..

6

Balancing Benefits And Harms In Health Care:

Cervi, Paul L. ; Randev, Pawan ; Shaw, Joanne M....
BMJ: British Medical Journal. 329 (2004) 7463 - p. 457-459 , 2004

Link: https://www.jstor.org/st..

7

A clinician's guide to biosimilars in oncology:

Rugo, Hope S ; Linton, Kim ; Cervi, Paul..
Rugo , H S , Linton , K , Cervi , P , Rosenberg , J A & Jacobs , I 2016 , ' A clinician's guide to biosimilars in oncology ' , Cancer Treatment Reviews , vol. 46 , pp. 73-79 . https://doi.org/10.1016/j.ctrv.2016.04.003. , 2016

Link: https://research.manches..

8